MAY 4-7, 2025 | SCOTTSDALE, AZ

Registration is now open!

Registration includes meals for the conference days!

Presented by the UCSF Department of Laboratory Medicine and UCSF Center for Research in Transfusion Medicine and Cellular Therapies

Co-hosted by Colorado State University and the Armed Forces Institute of Regenerative Medicine

This is the sixth in a series of conferences entitled “Cellular Therapies and Transfusion Medicine in Trauma and Critical Care Medicine” It is our belief that cellular therapies, adjuncts in resuscitation and novel blood products represent critical areas in transfusion medicine that have the potential to dramatically improve outcomes in trauma patients. Previous conferences have resulted in multiple cross-disciplinary collaborations and grants for pre-clinical studies and clinical trials.

Our mission is highly focused on supporting the development and translation of novel therapies in trauma and critical care medicine. The goal of our meeting is to bring together the expertise and input of blood bankers, cell therapy producers, clinicians, basic scientists, industry, FDA, NIH, AABB, DARPA, BARDA and DOD representatives to discuss current research and existing barriers in the translation of these novel therapies in trauma and critical care medicine, a field with limited therapeutic options and unlimited opportunities for advancement.

CTTACC Sessions

Lessons Learned from COVID-19: The Therapeutic Potential of Cellular Therapies and Blood Products
The First Cell Therapy: Whole Blood Use in the Military and Civilian Sectors
Novel and Stem Cell Derived Blood Products
Blood Shortages and Adjunctive Therapies to Address the Shortages
Product Development for Threat X- session-BARDA session
Stem Cells and Regenerative Medicine in Trauma and Critical Care
Cellular and Novel Therapeutics in Neurotrauma and Polytrauma
One Health Driving Translational Development
Funding and Sustainability of Research
Optimizing Clinical Trial Design to Support Advancement of Novel Therapies in Trauma and Critical Care
Challenges of Product Development in Cell Therapies and Novel Blood Products: the Similarities and Differences

Cellular Therapies Topics

Spinal Cord Injury (SCI)
Traumatic Brain Injury (TBI)
Hemorrhagic Shock
Wound Healing
Orthopedic Injury
Organ Failure
Acute Respiratory Distress Syndrome (ARDS)
Acute Kidney Injury (AKI)
Cell Processing and Product Development
Cardiovascular Disease

Novel Blood Product and Transfusion Topics

Whole Blood Transfusion
Hemorrhage Control
Adjunct to Resuscitation
Stem Cell Derived Blood Products
Dried Plasma and Platelets
Cold Stored Platelets
Platelet Extracellular Vesicles


Questions? Email us at [email protected] or call 303-238-0685